Ingevity (NYSE:NGVT) Issues Quarterly Earnings Results, Beats Estimates By $0.41 EPS

Ingevity (NYSE:NGVT) released its quarterly earnings results on Wednesday. The company reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41, FiscalAI reports. The firm had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. Ingevity updated its FY 2026 guidance to 5.000-5.450 EPS.

Ingevity Price Performance

Shares of NYSE NGVT traded down $3.41 during trading on Wednesday, reaching $71.08. The company had a trading volume of 387,158 shares, compared to its average volume of 202,450. Ingevity has a 52 week low of $39.74 and a 52 week high of $79.29. The business’s 50 day moving average price is $71.53 and its 200-day moving average price is $70.91. The stock has a market cap of $2.47 billion, a PE ratio of 16.82 and a beta of 1.16. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42.

Insider Activity at Ingevity

In related news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.88% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. AQR Capital Management LLC increased its stake in shares of Ingevity by 10.9% in the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock valued at $518,000 after buying an additional 1,323 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Ingevity by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after acquiring an additional 1,080 shares during the period. Empowered Funds LLC lifted its stake in shares of Ingevity by 12.9% during the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after acquiring an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in Ingevity by 306.1% in the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after acquiring an additional 66,995 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $80.00.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.